BackMatinas Biopharma Holdings Overview

Matinas Biopharma Holdings Other Liabilities

Track Matinas Biopharma Holdings's other liabilities ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Matinas Biopharma Holdings Other Liabilities History

Loading

Matinas Biopharma Holdings vs. peers: Other Liabilities Comparison

Loading

Matinas Biopharma Holdings Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Matinas Biopharma Holdings (MTNB) FAQ

Matinas Biopharma Holdings (MTNB) currently reports a other liabilities of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Matinas Biopharma Holdings's other liabilities history and peer comparisons.

Matinas Biopharma Holdings's other liabilities changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Matinas Biopharma Holdings reported $0 in other liabilities as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Matinas Biopharma Holdings, and consider following MTNB for alerts when major investors trade the stock.

Matinas Biopharma Holdings is classified in the Healthcare sector. On other liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MTNB with unrelated industries.